Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    11172152 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Antimalarial Drug Resistance in Mali
Condition: Malaria
Interventions: Drug: chloroquine;   Drug: sulfadoxine-pyrimethamine;   Drug: amodiaquine;   Drug: amodiaquine+artesunate;   Drug: amodiaquine+sulfadoxine-pyrimethamine;   Drug: sulfadoxine-pyrimethamine+artesunate;   Drug: artemether-lumefantrine;   Drug: mefloquine
2 Completed Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
Condition: Drug Resistant Malaria Due to Plasmodium Falciparum
Interventions: Drug: Arthemeter-lumefantrine;   Drug: Artesunate mefloquine;   Drug: Dihydroartemisinin piperaquine;   Drug: Paracetamol;   Drug: Amoxicillin;   Drug: Quinine
3 Recruiting Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)
Conditions: Malaria,Falciparum;   Children, Only
Interventions: Biological: RABIPUR®;   Biological: RTS,S/AS01;   Drug: SMC with SP+AQ;   Drug: SMC placebo

Study has passed its completion date and status has not been verified in more than two years.